BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 9758213)

  • 1. Cortical variability and asymmetry in normal aging and Alzheimer's disease.
    Thompson PM; Moussai J; Zohoori S; Goldkorn A; Khan AA; Mega MS; Small GW; Cummings JL; Toga AW
    Cereb Cortex; 1998 Sep; 8(6):492-509. PubMed ID: 9758213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.
    Thompson PM; Mega MS; Woods RP; Zoumalan CI; Lindshield CJ; Blanton RE; Moussai J; Holmes CJ; Cummings JL; Toga AW
    Cereb Cortex; 2001 Jan; 11(1):1-16. PubMed ID: 11113031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulcal variability in the Alzheimer's brain: correlations with cognition.
    Mega MS; Thompson PM; Cummings JL; Back CL; Xu ML; Zohoori S; Goldkorn A; Moussai J; Fairbanks L; Small GW; Toga AW
    Neurology; 1998 Jan; 50(1):145-51. PubMed ID: 9443471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping cortical asymmetry and complexity patterns in normal children.
    Blanton RE; Levitt JG; Thompson PM; Narr KL; Capetillo-Cunliffe L; Nobel A; Singerman JD; McCracken JT; Toga AW
    Psychiatry Res; 2001 Jul; 107(1):29-43. PubMed ID: 11472862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces.
    Thompson PM; MacDonald D; Mega MS; Holmes CJ; Evans AC; Toga AW
    J Comput Assist Tomogr; 1997; 21(4):567-81. PubMed ID: 9216760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional statistical analysis of sulcal variability in the human brain.
    Thompson PM; Schwartz C; Lin RT; Khan AA; Toga AW
    J Neurosci; 1996 Jul; 16(13):4261-74. PubMed ID: 8753887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study.
    Gee J; Ding L; Xie Z; Lin M; DeVita C; Grossman M
    Acad Radiol; 2003 Dec; 10(12):1392-401. PubMed ID: 14697007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain.
    Thompson PM; Schwartz C; Toga AW
    Neuroimage; 1996 Feb; 3(1):19-34. PubMed ID: 9345472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.
    Tosun D; Mojabi P; Weiner MW; Schuff N
    Neuroimage; 2010 Aug; 52(1):186-97. PubMed ID: 20406691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corpus callosum in Alzheimer's disease and vascular dementia--a quantitative magnetic resonance study.
    Pantel J; Schröder J; Essig M; Minakaran R; Schad LR; Friedlinger M; Jauss M; Knopp MV
    J Neural Transm Suppl; 1998; 54():129-36. PubMed ID: 9850921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
    Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Shape Perception in Posterior Cortical Atrophy: A Visual Neuroscience Perspective.
    Gillebert CR; Schaeverbeke J; Bastin C; Neyens V; Bruffaerts R; De Weer AS; Seghers A; Sunaert S; Van Laere K; Versijpt J; Vandenbulcke M; Salmon E; Todd JT; Orban GA; Vandenberghe R
    J Neurosci; 2015 Sep; 35(37):12673-92. PubMed ID: 26377458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
    Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Hayashi T; Oyanagi C; Konishi J; Shio H
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices.
    Sowell ER; Thompson PM; Rex D; Kornsand D; Tessner KD; Jernigan TL; Toga AW
    Cereb Cortex; 2002 Jan; 12(1):17-26. PubMed ID: 11734529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional probabilistic maps of the occipital sulci of the human brain in standardized stereotaxic space.
    Iaria G; Robbins S; Petrides M
    Neuroscience; 2008 Jan; 151(1):174-85. PubMed ID: 18054173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical sulcal maps in autism.
    Levitt JG; Blanton RE; Smalley S; Thompson PM; Guthrie D; McCracken JT; Sadoun T; Heinichen L; Toga AW
    Cereb Cortex; 2003 Jul; 13(7):728-35. PubMed ID: 12816888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
    Acosta O; Fripp J; Doré V; Bourgeat P; Favreau JM; Chételat G; Rueda A; Villemagne VL; Szoeke C; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Bonner E; Gris F; Xiao D; Raniga P; Barra V; Salvado O
    J Neurosci Methods; 2012 Mar; 205(1):96-109. PubMed ID: 22226742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.